03:25 AM EST, 12/09/2024 (MT Newswires) -- Justin Chakma, Chief Business Officer, on December 04, 2024, sold 144,640 shares in ARS Pharmaceuticals ( SPRY ) for $2,041,200. Following the Form 4 filing with the SEC, Chakma has control over a total of 136,380 shares of the company, with 136,380 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588924028567/xslF345X05/form4-12072024_121247.xml